{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:35:09Z","timestamp":1780608909139,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","award":["2022-LCYJ-PY-40"],"award-info":[{"award-number":["2022-LCYJ-PY-40"]}],"id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["QRX17142"],"award-info":[{"award-number":["QRX17142"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["YKK21066"],"award-info":[{"award-number":["YKK21066"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.imlet.2023.04.010","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T20:03:24Z","timestamp":1682798604000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Correlation of serum adenosine deaminase activity with disease activity in patients with primary Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"258","author":[{"given":"Hairong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1365-5777","authenticated-orcid":false,"given":"Kunzhan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9636-6298","authenticated-orcid":false,"given":"Sen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2023.04.010_bib0001","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","article-title":"Current and future therapies for primary Sj\u00f6gren syndrome","volume":"17","author":"Seror","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sj\u00f6gren's syndrome: a systemic autoimmune disease","volume":"22","author":"Negrini","year":"2021","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.imlet.2023.04.010_bib0003","article-title":"Candidate autoantibodies for primary Sjogren's syndrome: where are they now?","author":"He","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0004","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/art.22658","article-title":"Sjogren's syndrome disease damage index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjogren's syndrome, derived from an analysis of a cohort of Italian patients","volume":"56","author":"Vitali","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2023.04.010_bib0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO;2-U","article-title":"Adenosine deaminase: functional implications and different classes of inhibitors","volume":"21","author":"Cristalli","year":"2001","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.imlet.2023.04.010_bib0006","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1016\/S0021-9258(17)33080-6","article-title":"Human adenosine deaminase. Distribution and properties","volume":"251","author":"Van der Weyden","year":"1976","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2023.04.010_bib0007","first-page":"266","article-title":"Adenosine deaminase isoenzymes in liver disease","volume":"88","author":"Kobayashi","year":"1993","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0008","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/138945012800564095","article-title":"Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders","volume":"13","author":"Antonioli","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.imlet.2023.04.010_bib0009","first-page":"12","article-title":"Adenosine-metabolizing enzymes, adenosine kinase and adenosine deaminase, in cancer","author":"Zhulai","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.imlet.2023.04.010_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102709","article-title":"The roles of adenosine deaminase in autoimmune diseases","volume":"20","author":"Gao","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2023.04.010_bib0011","first-page":"288","article-title":"[Role of biomarkers in making the diagnosis of tuberculous pleurisy]","volume":"79","author":"Klimiuk","year":"2011","journal-title":"Pneumonol. Alergol. Pol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0012","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MCP.0b013e32833a7154","article-title":"Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis","volume":"16","author":"Krenke","year":"2010","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.imlet.2023.04.010_bib0013","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12865-022-00477-5","article-title":"Increased serum adenosine deaminase activity in patients with adult-onset Still's disease","volume":"23","author":"Xu","year":"2022","journal-title":"BMC Immunol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0014","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s12026-016-8870-2","article-title":"The role of adenosinergic pathway in human autoimmune diseases","volume":"64","author":"Dong","year":"2016","journal-title":"Immunol. Res."},{"key":"10.1016\/j.imlet.2023.04.010_bib0015","first-page":"418","article-title":"Adenosine-metabolizing enzymes, adenosine kinase and adenosine deaminase, in cancer","volume":"12","author":"Zhulai","year":"2022","journal-title":"Biomolecules (Basel, Switzerland)"},{"issue":"Suppl 1","key":"10.1016\/j.imlet.2023.04.010_bib0016","first-page":"S27","article-title":"Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction","volume":"153","author":"Palmer","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0017","article-title":"The immunomodulatory function of adenosine in sepsis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030784","article-title":"The inside story of adenosine","volume":"19","author":"Camici","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2023.04.010_bib0019","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","article-title":"Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells","volume":"74","author":"Kaljas","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.imlet.2023.04.010_bib0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0021","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-nutr-071811-150709","article-title":"New roles of HDL in inflammation and hematopoiesis","volume":"32","author":"Zhu","year":"2012","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.imlet.2023.04.010_bib0022","article-title":"HDL in immune-inflammatory responses: implications beyond cardiovascular diseases","volume":"10","author":"Bonacina","year":"2021","journal-title":"Cells-Basel"},{"key":"10.1016\/j.imlet.2023.04.010_bib0023","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2172-11-46","article-title":"Serum lipoproteins attenuate macrophage activation and toll-like receptor stimulation by bacterial lipoproteins","volume":"11","author":"Bas","year":"2010","journal-title":"BMC Immunol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0024","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbrc.2017.01.138","article-title":"High-density lipoprotein and apolipoprotein A-I inhibit palmitate-induced translocation of toll-like receptor 4 into lipid rafts and inflammatory cytokines in 3T3-L1 adipocytes","volume":"484","author":"Yamada","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imlet.2023.04.010_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/jir.2019.0029","article-title":"High-density lipoproteins decrease proinflammatory activity and modulate the innate immune response","volume":"39","author":"Taborda","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.imlet.2023.04.010_bib0026","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejr.2022.05.002","article-title":"Hematologic parameters and disease activity in patients with primary Sj\u00f6gren's syndrome","volume":"44","author":"Abbasi Moghaddam","year":"2022","journal-title":"Egypt. Rheumatol."},{"key":"10.1016\/j.imlet.2023.04.010_bib0027","doi-asserted-by":"crossref","DOI":"10.1093\/mr\/road010","article-title":"Hyperglobulinemia predicts increased risk of mortality in primary Sjogren's syndrome: based on a Chinese multicentre registry","author":"Zhong","year":"2023","journal-title":"Mod. Rheumatol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247823000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247823000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:42:10Z","timestamp":1759045330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247823000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"alternative-id":["S0165247823000706"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2023.04.010","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of serum adenosine deaminase activity with disease activity in patients with primary Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2023.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}